Cargando…

Impact of antigen avoidance test for fibrotic hypersensitivity pneumonitis in stable phase

BACKGROUND: The antigen avoidance has been used in the diagnosis and treatment of hypersensitivity pneumonitis (HP); however, its usefulness in stable fibrotic HP is controversial. OBJECTIVE: To investigate the usefulness of the antigen avoidance test in patients with fibrotic HP in stable phase. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okuda, Ryo, Takemura, Tamiko, Iwasawa, Tae, Kaburaki, Shota, Baba, Tomohisa, Hagiwara, Eri, Ogura, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733398/ https://www.ncbi.nlm.nih.gov/pubmed/36494847 http://dx.doi.org/10.1186/s13223-022-00748-1

Ejemplares similares

Multidisciplinary Discussion for Fibrotic Hypersensitivity Pneumonitis with a Positive Antigen Avoidance
por: Okuda, Ryo, et al.
Publicado: (2023)

The new useful high-resolution computed tomography finding for diagnosing fibrotic hypersensitivity pneumonitis: “hexagonal pattern”: a single-center retrospective study
por: Okabayashi, Hiroko, et al.
Publicado: (2022)

Antigen avoidance and outcome of nonfibrotic and fibrotic hypersensitivity pneumonitis
por: Nishida, Takashi, et al.
Publicado: (2021)

Antigen avoidance and environmental inhalation challenge for successful diagnosis of fibrotic hypersensitivity pneumonitis mimicking idiopathic pulmonary fibrosis
por: Ito, Yasuhiro, et al.
Publicado: (2022)

Clusters of comorbidities in fibrotic hypersensitivity pneumonitis
por: Prior, Thomas Skovhus, et al.
Publicado: (2022)

Prognostic Factors in Interstitial Lung Disease Associated with Primary Sjögren’s Syndrome: A Retrospective Analysis of 33 Pathologically–Proven Cases
por: Enomoto, Yasunori, et al.
Publicado: (2013)

Usefulness and safety of transbronchial lung cryobiopsy for reassessment of treatment in the clinical course of diffuse parenchymal lung disease
por: Sato, Yozo, et al.
Publicado: (2022)

Clinical characteristics of hypersensitivity pneumonitis: non-fibrotic and fibrotic subtypes
por: Chen, Xueying, et al.
Publicado: (2023)

A 16-year Follow-up Case of Interstitial Pneumonia with Systemic Sclerosis-rheumatoid Arthritis Overlap Syndrome
por: Yamakawa, Hideaki, et al.
Publicado: (2017)

Fibrotic Hypersensitivity Pneumonitis: Key Issues in Diagnosis and Management
por: Kouranos, Vasileios, et al.
Publicado: (2017)

Acute exacerbation of fibrotic hypersensitivity pneumonitis: incidence and outcomes
por: Kang, Jieun, et al.
Publicado: (2021)

Diagnosis of Fibrotic Hypersensitivity Pneumonitis: Is There a Role for Biomarkers?
por: Pereira, João O., et al.
Publicado: (2023)

Outcome of COVID-19 in interstitial lung disease patients treated with anti-inflammatory drugs and antiviral drugs
por: Yamaya, Takafumi, et al.
Publicado: (2022)

Barriers to antigen detection and avoidance in chronic hypersensitivity pneumonitis in the United States
por: Aronson, Kerri I., et al.
Publicado: (2021)

Features of transbronchial lung cryobiopsy‐diagnosed fibrotic hypersensitivity pneumonitis
por: Zhan, Xi, et al.
Publicado: (2022)

Fibrosis score predicts mortality in patients with fibrotic hypersensitivity pneumonitis
por: Oh, Ju Hyun, et al.
Publicado: (2023)

Long-term clinical course of anti-glycyl tRNA synthetase (anti-EJ) antibody-related interstitial lung disease pathologically proven by surgical lung biopsy
por: Sasano, Hajime, et al.
Publicado: (2016)

Clinical Features of Idiopathic Interstitial Pneumonia with Systemic Sclerosis-Related Autoantibody in Comparison with Interstitial Pneumonia with Systemic Sclerosis
por: Yamakawa, Hideaki, et al.
Publicado: (2016)

Environmental levels of avian antigen are relevant to the progression of chronic hypersensitivity pneumonitis during antigen avoidance
por: Sema, Manabu, et al.
Publicado: (2017)

Criteria for progressive fibrotic hypersensitivity pneumonitis in a Portuguese patient cohort
por: Seixas, E, et al.
Publicado: (2022)

A Retrospective Study of the Clinical, Radiological, and Pathological Characteristics of Patients with Interstitial Pneumonia Preceding Rheumatoid Arthritis
por: Sato, Midori, et al.
Publicado: (2022)

Concordance between transbronchial lung cryobiopsy and surgical lung biopsy for interstitial lung disease in the same patients
por: Baba, Tomohisa, et al.
Publicado: (2023)

Negative impact of anorexia and weight loss during prior pirfenidone administration on subsequent nintedanib treatment in patients with idiopathic pulmonary fibrosis
por: Ikeda, Satoshi, et al.
Publicado: (2019)

Low body surface area predicts hepatotoxicity of nintedanib in patients with idiopathic pulmonary fibrosis
por: Ikeda, Satoshi, et al.
Publicado: (2017)

Randomized phase II study of nintedanib with or without pirfenidone in patients with idiopathic pulmonary fibrosis who experienced disease progression during prior pirfenidone administration
por: Ikeda, Satoshi, et al.
Publicado: (2022)

Characterizing cellular heterogeneity in fibrotic hypersensitivity pneumonitis by single-cell transcriptional analysis
por: Wang, Junyi, et al.
Publicado: (2022)

Dyskeratosis congenita with heterozygous RTEL1 mutations presenting with fibrotic hypersensitivity pneumonitis
por: Han, Jinhee, et al.
Publicado: (2023)

Anti-Inflammatory and/or Anti-Fibrotic Treatment of MPO-ANCA-Positive Interstitial Lung Disease: A Short Review
por: Yamakawa, Hideaki, et al.
Publicado: (2022)

Disruption in the balance between apolipoprotein A‐I and mast cell chymase in chronic hypersensitivity pneumonitis
por: Inoue, Yukihisa, et al.
Publicado: (2020)

Emphysema formation in a never-smoker with scleroderma-related interstitial pneumonia
por: Yamakawa, Hideaki, et al.
Publicado: (2018)

Radiological and Pathological Features of Cyst Formation in Idiopathic Multicentric Castleman Disease
por: Otoshi, Ryota, et al.
Publicado: (2023)

Anti-Ku antibody-positive desquamative interstitial pneumonia
por: Otoshi, Ryota, et al.
Publicado: (2018)

Performance of a diagnostic algorithm for fibrotic hypersensitivity pneumonitis. A case–control study
por: Guler, Sabina A., et al.
Publicado: (2021)

Challenges in the Diagnosis and Management of Fibrotic Hypersensitivity Pneumonitis: A Practical Review of Current Approaches
por: Moua, Teng, et al.
Publicado: (2022)

Short‐term lung function changes predict mortality in patients with fibrotic hypersensitivity pneumonitis
por: Macaluso, Claudio, et al.
Publicado: (2022)

Fibrotic Hypersensitivity Pneumonitis Diagnosed by a Re-evaluation with Bronchoalveolar Lavage at Disease Deterioration
por: Moda, Mitsuhiro, et al.
Publicado: (2022)

Mortality risk prediction with ILD-GAP index in a fibrotic hypersensitivity pneumonitis cohort
por: Mendonça Almeida, Leonor, et al.
Publicado: (2022)

Impact of radiographic honeycombing on transplant free survival and efficacy of immunosuppression in fibrotic hypersensitivity pneumonitis
por: Adams, Traci N., et al.
Publicado: (2023)

Higher serum CCL17 may be a promising predictor of acute exacerbations in chronic hypersensitivity pneumonitis
por: Miyazaki, Yasunari, et al.
Publicado: (2013)

Hypersensitivity pneumonitis
por: Lacasse, Yves, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_dh0sk5nno61a1bi1u21n4sntv7